Ironwood Pharmaceuticals (IRWD) Stock: Why It's Up Today
Updated Oct 20, 2026, 1:16 PM ET · intraday price
- Trading at $3.66 as of 1:16 PM ET, +2.81% vs the prior close of $3.56.
- Volume 816.73K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Pfizer (PFE)
IRWD rises 2.8% to $3.66. Trading at $3.66 (intraday, 1:16 PM ET), +2.81% vs the prior close of $3.56. Day range $3.53–$3.71, opened at $3.57.
IRWD daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 20, 2026 — IRWD rises 2.8% to $3.66
- Trading at $3.66 (intraday, 1:16 PM ET), +2.81% vs the prior close of $3.56. Day range $3.53–$3.71, opened at $3.57.
- Volume was 816.73K shares, 0.4x its 50-day average of 1.92M — lighter than usual.
- Price is -10.2% vs its 50-day average ($4.08) and -8.9% vs its 200-day average ($4.02).
- 52-week range $1.44–$5.78; the current price sits at 51% of that range, 36.7% below the 52-week high.
Oct 19, 2026 — IRWD rises 1.7% to $3.56
- Closed at $3.56, +1.71% vs the prior close of $3.50. Day range $3.47–$3.59, opened at $3.53.
- Volume was 1.68M shares, 0.9x its 50-day average of 1.93M.
- Price is -12.8% vs its 50-day average ($4.08) and -11.5% vs its 200-day average ($4.02).
- 52-week range $1.43–$5.78; today's close sits at 49% of that range, 38.4% below the 52-week high.
Oct 16, 2026 — IRWD slides 7.2% to $3.50, a 3-month low
- Closed at $3.50, -7.16% vs the prior close of $3.77. Day range $3.48–$3.73, opened at $3.70.
- Volume was 2.53M shares, 1.3x its 50-day average of 1.94M.
- Price is -14.6% vs its 50-day average ($4.10) and -12.9% vs its 200-day average ($4.02).
- 52-week range $1.43–$5.78; today's close sits at 48% of that range, 39.4% below the 52-week high.
Oct 15, 2026 — IRWD jumps 4.7% to $3.77
- Closed at $3.77, +4.72% vs the prior close of $3.60. Day range $3.63–$3.87, opened at $3.63.
- Volume was 2.04M shares, 1.1x its 50-day average of 1.95M.
- Price is -8.3% vs its 50-day average ($4.11) and -6.2% vs its 200-day average ($4.02).
- 52-week range $1.43–$5.78; today's close sits at 54% of that range, 34.8% below the 52-week high.
Oct 14, 2026 — IRWD ends flat (+0.3%) to $3.60
- Closed at $3.60, +0.28% vs the prior close of $3.59. Day range $3.51–$3.63, opened at $3.55.
- Volume was 1.22M shares, 0.6x its 50-day average of 2.04M.
- Price is -12.6% vs its 50-day average ($4.12) and -10.4% vs its 200-day average ($4.02).
- 52-week range $1.41–$5.78; today's close sits at 50% of that range, 37.7% below the 52-week high.
Oct 13, 2026 — IRWD slides 4.5% to $3.59, a 1-month low, 3 down days in a row
- Closed at $3.59, -4.52% vs the prior close of $3.76. Day range $3.55–$3.78, opened at $3.74.
- Volume was 2.11M shares, 1.0x its 50-day average of 2.07M.
- Price is -13.2% vs its 50-day average ($4.14) and -10.6% vs its 200-day average ($4.01).
- 52-week range $1.41–$5.78; today's close sits at 50% of that range, 37.9% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — IRWD dips 1.6% to $3.76
- Closed at $3.76, -1.57% vs the prior close of $3.82. Day range $3.74–$3.85, opened at $3.82.
- Volume was 1.04M shares, 0.5x its 50-day average of 2.12M — lighter than usual.
- Price is -9.4% vs its 50-day average ($4.15) and -6.3% vs its 200-day average ($4.01).
- 52-week range $1.41–$5.78; today's close sits at 54% of that range, 34.9% below the 52-week high.
Oct 9, 2026 — IRWD dips 1.3% to $3.82
- Closed at $3.82, -1.29% vs the prior close of $3.87. Day range $3.81–$3.95, opened at $3.88.
- Volume was 1.72M shares, 0.8x its 50-day average of 2.11M.
- Price is -8.2% vs its 50-day average ($4.16) and -4.7% vs its 200-day average ($4.01).
- 52-week range $1.41–$5.78; today's close sits at 55% of that range, 33.9% below the 52-week high.
Oct 8, 2026 — IRWD jumps 3.2% to $3.87
- Closed at $3.87, +3.20% vs the prior close of $3.75. Day range $3.67–$3.97, opened at $3.70.
- Volume was 2.40M shares, 1.1x its 50-day average of 2.09M.
- Price is -7.0% vs its 50-day average ($4.16) and -3.4% vs its 200-day average ($4.01).
- 52-week range $1.41–$5.78; today's close sits at 56% of that range, 33.0% below the 52-week high.
Oct 7, 2026 — IRWD jumps 3.3% to $3.75
- Closed at $3.75, +3.31% vs the prior close of $3.63. Day range $3.54–$3.87, opened at $3.58.
- Volume was 2.05M shares, 1.0x its 50-day average of 2.09M.
- Price is -9.7% vs its 50-day average ($4.15) and -6.3% vs its 200-day average ($4.00).
- 52-week range $1.41–$5.78; today's close sits at 54% of that range, 35.1% below the 52-week high.
Oct 6, 2026 — IRWD dips 0.5% to $3.63, a 1-month low
- Closed at $3.63, -0.55% vs the prior close of $3.65. Day range $3.60–$3.68, opened at $3.64.
- Volume was 1.87M shares, 0.9x its 50-day average of 2.09M.
- Price is -12.6% vs its 50-day average ($4.15) and -9.3% vs its 200-day average ($4.00).
- 52-week range $1.41–$5.78; today's close sits at 51% of that range, 37.2% below the 52-week high.
Oct 5, 2026 — IRWD ends flat (+0.3%) to $3.65
- Closed at $3.65, +0.27% vs the prior close of $3.64. Day range $3.55–$3.67, opened at $3.59.
- Volume was 2.23M shares, 1.1x its 50-day average of 2.07M.
- Price is -12.3% vs its 50-day average ($4.16) and -8.7% vs its 200-day average ($4.00).
- 52-week range $1.41–$5.78; today's close sits at 51% of that range, 36.9% below the 52-week high.
Oct 2, 2026 — IRWD slides 3.2% to $3.64, a 1-month low, 3 down days in a row
- Closed at $3.64, -3.19% vs the prior close of $3.76. Day range $3.58–$3.80, opened at $3.74.
- Volume was 2.70M shares, 1.3x its 50-day average of 2.03M.
- Price is -12.5% vs its 50-day average ($4.16) and -9.0% vs its 200-day average ($4.00).
- 52-week range $1.41–$5.78; today's close sits at 51% of that range, 37.0% below the 52-week high.
- That makes 3 straight losses.
IRWD bull case vs bear case (from the data)
- Latest fiscal-year net income: profit of $24.02M.
- Price is -10.2% vs its 50-day average — short-term trend is down.
- Price is -8.9% vs its 200-day average — below the long-term trend line.
- Annual revenue fell 15.7% in the latest fiscal year (SEC XBRL).
- Insider selling outweighs buying: 25 sales vs 0 open-market buys among the 25 most recent reported insider trades (Form 4, last 12 months).
IRWD latest news & SEC filings
Every SEC filing by or about IRWD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 23, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Denner Alexander J received an award of 3,694 shares on Sep 15, 2026; now holds 327,549
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 7, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $113.04M (prior year $85.24M) (+32.6% vs Jun 30, 2025)
- Net income: $51.29M (prior year $23.60M) (+117.3% vs Jun 30, 2025)
- Diluted EPS: $0.31 (prior year $0.14) (+121.4% vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 28, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 22, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Jul 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Silver Ronald sold 127,890 shares at $4.52 (≈$578.06K) on Jul 7, 2026
- Silver Ronald sold 127,890 shares at $4.52 (≈$578.06K) on Jul 7, 2026
- Silver Ronald sold 127,890 shares at $4.52 (≈$578.06K) on Jul 7, 2026
- Silver Ronald sold 127,890 shares at $4.52 (≈$578.06K) on Jul 7, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 7, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Things to know before you trade IRWD
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Feb 25, 2026, Jan 2, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.74% (largest 7.2%).
- Liquidity: about 1.83M shares (≈$6.70M) trade per day on average.
- 52-week position: $3.66 vs a range of $1.44–$5.78 (51% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Ronald Silver sold 127,890 shares on Jul 7, 2026.
- Latest filings: 8-K Oct 16, 2026; 10-Q Aug 6, 2026; 8-K Aug 6, 2026.
- Share count: 165.24M shares outstanding (Jul 31, 2026), +1.7% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
IRWD market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 3.57 | 3.71 | 3.53 | 3.66 | 816.73K |
| Oct 19, 2026 | 3.53 | 3.59 | 3.48 | 3.56 | 1.68M |
| Oct 16, 2026 | 3.73 | 3.73 | 3.48 | 3.50 | 2.53M |
| Oct 15, 2026 | 3.63 | 3.87 | 3.63 | 3.77 | 2.04M |
| Oct 14, 2026 | 3.55 | 3.63 | 3.51 | 3.60 | 1.22M |
| Oct 13, 2026 | 3.74 | 3.78 | 3.55 | 3.59 | 2.11M |
| Oct 12, 2026 | 3.82 | 3.85 | 3.74 | 3.76 | 1.04M |
| Oct 9, 2026 | 3.88 | 3.95 | 3.81 | 3.82 | 1.72M |
| Oct 8, 2026 | 3.70 | 3.97 | 3.67 | 3.87 | 2.40M |
| Oct 7, 2026 | 3.58 | 3.87 | 3.54 | 3.75 | 2.05M |
| Oct 6, 2026 | 3.64 | 3.68 | 3.60 | 3.63 | 1.87M |
| Oct 5, 2026 | 3.59 | 3.67 | 3.55 | 3.65 | 2.23M |
| Oct 2, 2026 | 3.74 | 3.80 | 3.58 | 3.64 | 2.70M |
| Oct 1, 2026 | 3.95 | 3.97 | 3.74 | 3.76 | 2.63M |
| Sep 30, 2026 | 4.16 | 4.17 | 3.96 | 3.97 | 1.66M |
| Sep 29, 2026 | 4.12 | 4.17 | 4.08 | 4.16 | 1.23M |
| Sep 28, 2026 | 4.09 | 4.17 | 4.04 | 4.12 | 1.96M |
| Sep 25, 2026 | 4.22 | 4.25 | 4.10 | 4.13 | 1.32M |
| Sep 24, 2026 | 4.23 | 4.26 | 4.05 | 4.19 | 1.74M |
| Sep 23, 2026 | 4.50 | 4.54 | 4.25 | 4.27 | 1.66M |
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (IRWD) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in BOSTON, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1446847.
IRWD board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Mark G Currie | Director | Jun 17, 2026 |
| Alexander J Denner | Director | Sep 17, 2026 |
| Jon R Duane | Director | Jun 17, 2026 |
| Marla L Kessler | Director | Jun 17, 2026 |
| Thomas A Mccourt | Chief Executive Officer | Mar 12, 2026 |
| Julie Mchugh | Director | Jun 17, 2026 |
| Catherine Moukheibir | Director | Jun 17, 2026 |
| Jay Shepard | Director | Jun 17, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Tammi L Gaskins | Chief Commercial Officer | Mar 12, 2026 |
| Minardo John | Chief Legal Officer | Mar 12, 2026 |
| Thomas A Mccourt | Chief Executive Officer | Mar 12, 2026 |
| Gregory S. Martini | Chief Financial Officer | Mar 12, 2026 |
| Michael Shetzline | SVP, CMO, Head-Res&Drug | Mar 12, 2026 |
| Jeffrey Silber | SVP, CMO, Head-Res&Drug | Jul 22, 2026 |
| Ronald Silver | PFO & PAO | Jul 9, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 7, 2026 | Ronald Silver | Sale | 127,890 | $4.52 |
| Jul 7, 2026 | Ronald Silver | Sale | 127,890 | $4.52 |
| Jul 7, 2026 | Ronald Silver | Sale | 127,890 | $4.52 |
| Jul 7, 2026 | Ronald Silver | Sale | 127,890 | $4.52 |
| Jun 16, 2026 | Julie Mchugh | Sale | 21,571 | $3.73 |
| Jun 16, 2026 | Julie Mchugh | Sale | 21,571 | $3.73 |
| Jun 16, 2026 | Julie Mchugh | Sale | 21,571 | $3.73 |
| Jun 16, 2026 | Julie Mchugh | Sale | 21,571 | $3.73 |
| Mar 17, 2026 | Alexander J Denner | Sale | 5,800 | $3.31 |
| Mar 17, 2026 | Alexander J Denner | Sale | 6,725,000 | $3.05 |
| Mar 17, 2026 | Alexander J Denner | Sale | 5,800 | $3.31 |
| Mar 17, 2026 | Alexander J Denner | Sale | 6,725,000 | $3.05 |
| Mar 17, 2026 | Alexander J Denner | Sale | 5,800 | $3.31 |
| Mar 17, 2026 | Alexander J Denner | Sale | 6,725,000 | $3.05 |
| Mar 17, 2026 | Alexander J Denner | Sale | 5,800 | $3.31 |
IRWD financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $296.15M | $24.02M | 0.15 | $127.04M |
| Dec 31, 2024 | $351.41M | $880.00K | 0.01 | $103.55M |
| Dec 31, 2023 | $442.74M | $-1.00B | -6.45 | $183.43M |
| Dec 31, 2022 | $410.60M | $175.06M | 0.96 | $273.76M |
| Dec 31, 2021 | $413.75M | $528.45M | 3.21 | $261.89M |
Latest balance sheet: total assets $285.13M, total liabilities $446.97M, cash $79.13M (as of Jun 30, 2026).
IRWD earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $4.26 |
| May 7, 2026 | 8-K Item 2.02 (results) | $4.17 |
| Feb 25, 2026 | 8-K Item 2.02 (results) | $3.36 |
| Jan 2, 2026 | 8-K Item 2.02 (results) | $4.27 |
| Nov 10, 2025 | 8-K Item 2.02 (results) | $2.53 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $0.88 |
| May 7, 2025 | 8-K Item 2.02 (results) | $0.79 |
| Apr 25, 2025 | 8-K Item 2.02 (results) | $0.89 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $1.62 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $4.66 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)United Therapeutics (UTHR)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Space Exploration Technologies (SPCX)Tesla (TSLA)Sandisk (SNDK)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on IRWD
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 20, 2026, 1:16 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.